BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, published by the Korean Society for Biotechnology and Bioengineering, is a prominent journal in the fields of applied microbiology, biotechnology, bioengineering, and biomedical engineering. Since its inception in 1996, this journal has served as a vital platform for researchers and professionals, facilitating the dissemination of cutting-edge research and innovative applications related to bioprocesses and biotechnology systems. With an ISSN of 1226-8372, this journal is ranked within the Q3 quartile across several categories, demonstrating its relevance and impact in the academic community. Although it operates under traditional access modalities, the journal strives to provide quality and timely insights into the advancements in bioprocess technology and microbial applications, fostering a collaborative environment for knowledge exchange. Notably, it is indexed with a respectable presence on Scopus, making it a valuable resource for students and professionals seeking the latest developments in biotechnology. For more details, kindly refer to the Korean Science Technology Center, #704 Yeoksam-Dong, Gangnam-Ku, Seoul 135-703, South Korea.

MICROBIOLOGICAL RESEARCH, published by Elsevier GmbH, serves as a leading platform for advancements in the field of Microbiology, holding an impressive Q1 ranking in its category as of 2023. With an ISSN of 0944-5013 and E-ISSN 1618-0623, this journal has been instrumental in disseminating high-quality research since its inception in 1994 and continues to contribute significantly to the academic landscape through 2024. Positioned within the top 13% of publications in the Immunology and Microbiology category, ranked #24 out of 182 according to Scopus, it attracts the attention of researchers, professionals, and students alike. While the journal is not open access, it offers vital insights and peer-reviewed articles that drive innovation and exploration within microbiological research. Its rigorous selection process underscores the importance of quality and relevance in advancing knowledge in this dynamic field.

BIOPROCESS AND BIOSYSTEMS ENGINEERING is a prestigious journal published by Springer, dedicated to advancing the field of bioengineering and biotechnology. Established in 1996, this influential journal provides a platform for disseminating high-quality research that covers a wide spectrum of topics related to bioprocessing, biosystems, and their applications in medicine and environmental engineering. With an impressive impact factor and ranking in the top quartile (Q2) across bioengineering, biotechnology, and miscellaneous medical fields, BIOPROCESS AND BIOSYSTEMS ENGINEERING stands out as a critical resource for researchers, professionals, and students. The journal is indexed in Scopus, reflecting its significant contribution to the scientific community, particularly with its robust percentile rankings (77th in Biotechnology and 70th in Bioengineering). Available in both print and electronic formats, this journal ensures accessible research for those pushing the boundaries of knowledge in bioprocessing and biosystems. As it continues to evolve, BIOPROCESS AND BIOSYSTEMS ENGINEERING encourages submissions that contribute to innovative research practices and applications, thereby fostering academic collaboration and advancement in this dynamic field.

Synthetic Biology, published by Oxford University Press, is a leading open-access journal that has gained recognition since its inception, becoming a pivotal platform in the fields of Agricultural and Biological Sciences, Bioengineering, Biomaterials, Biomedical Engineering, and Biotechnology. With an ISSN of 2397-7000 and consistent contributions from innovative researchers, the journal has established itself as a Q1 journal in Agricultural and Biological Sciences and ranks notably across various engineering disciplines, making it an essential resource for cutting-edge research and interdisciplinary collaboration. Since becoming fully open access in 2016, it has broadened its reach, allowing easy access to groundbreaking findings that drive advancements in synthetic biology and its applications. The journal's commitment to high-quality, peer-reviewed content serves to inspire researchers, professionals, and students alike, fostering a rich academic community dedicated to exploring the complexities of biological systems and their synthetic counterparts.

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

Molecular Metabolism is a premier, open-access journal published by Elsevier, dedicated to advancing the understanding of metabolic processes at the molecular level. With an ISSN of 2212-8778 and a proud presence in Germany, the journal has made significant contributions to the fields of Cell Biology and Molecular Biology, consistently achieving a Q1 ranking in both categories as of 2023. The journal’s scope encompasses cutting-edge research that explores metabolic pathways, their regulation, and implications for human health, underscoring the interplay between metabolism and various biological functions. Researchers and professionals benefit from the journal’s robust visibility, as it ranks #40 among 410 journals in Molecular Biology and #35 among 285 in Cell Biology according to Scopus metrics, placing it in the top 10 percentile in its field. With open access since 2012, Molecular Metabolism ensures that groundbreaking research is available to all, fostering a collaborative and inclusive academic environment. Its commitment to excellence and accessibility makes it an invaluable resource for those invested in metabolic research.

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

Cell Metabolism is an esteemed journal published by CELL PRESS, dedicated to advancing the understanding of metabolic processes within cell biology, molecular biology, and physiology. With an impactful 2023 ranking placing it at Q1 in multiple categories and earning a distinguished position in the top percentiles of its respective fields, this journal serves as an essential resource for researchers, professionals, and students who are investigating the dynamic roles of metabolism in health and disease. Its rigorous peer-review process ensures high-quality publications that reflect the latest advancements in metabolic research. Since its inception in 2005, Cell Metabolism has become a pivotal platform for disseminating critical findings that not only expand scientific knowledge but also foster innovative approaches to tackle metabolic disorders. By prioritizing accessibility and scholarly excellence without the Open Access model, it remains a premier source for cutting-edge research insights.

ENZYME AND MICROBIAL TECHNOLOGY, a premier journal published by Elsevier Science Inc, serves as a pivotal platform for researchers and professionals dedicated to exploring the dynamic intersections of microbiology, biochemistry, and bioengineering. With a rich publication history dating back to 1979 and converging until 2024, this journal has established itself within the Q2 quartile rankings across multiple categories, including Applied Microbiology and Biotechnology, Biochemistry, Bioengineering, and Biotechnology, highlighting its influential role in advancing scientific discourse. It holds impressive Scopus rankings, where it is recognized in the 79th percentile for Applied Microbiology and Biotechnology and ranks favorably in related fields, making it a valuable resource for academic and industrial researchers looking to stay abreast of the latest developments. Although it does not currently offer Open Access options, ENZYME AND MICROBIAL TECHNOLOGY remains an essential read for anyone invested in the biotechnological applications of enzymes and microorganisms.

BIOTECHNOLOGY PROGRESS, a prominent journal published by Wiley, stands at the forefront of the biotechnology field, delivering cutting-edge research and emerging trends since its inception in 1985. With an ISSN of 8756-7938 and an E-ISSN of 1520-6033, this journal has carved out a significant niche within the academic community, reflected in its Q2 ranking within the Biotechnology category for 2023. Maintaining a strong presence in the Scopus database, it ranks #111 out of 311 in the categories of Biochemistry, Genetics, and Molecular Biology, demonstrating its commitment to quality and significance in the field. Although it does not offer open access, it remains accessible through various institutional subscriptions, ensuring that vital biological and biotechnological discoveries reach a broad audience, including researchers, professionals, and students. Given its rigorous peer-review process and a focus on innovative methodologies, BIOTECHNOLOGY PROGRESS is an indispensable resource for anyone looking to stay informed about the latest advancements and applications in biotechnology.